Neuroblastoma in the adult. Effective combination chemotherapy
- 1 January 1978
Abstract
Although neuroblastoma occurs most frequently in children, it also may occur in adults and has been considered of poor prognosis. Six adult patients (>16 years of age) with widespread neuroblastoma diagnosed between 1974 and 1976 are described. Five were treated with a combination of cyclophosphamide, vincristine, adriamycin and dimethyl triazeno imidazole carboxamide (CYVADIC). The sixth received a similar regimen in which actinomycin D was substituted for dimethyl triazeno imidazole carboxamide (CYVADACT). There were two complete responses and three partial responses. The median duration of survival is in excess of 11 months. The results indicate that effective chemotherapy is now available for these patients and the achievement of remission and prolongation of survival are realistic goals in neuroblastoma.This publication has 18 references indexed in Scilit:
- Factors influencing survival of children with nonmetastatic neuroblastomaCancer, 1976
- Chemoimmunotherapy of Human Solid TumorsMedical Clinics of North America, 1976
- Diagnosis and Treatment of NeuroblastomaPediatric Clinics of North America, 1976
- Combination chemotherapy with adriamycin (NSC‐123127) and dimethyl triazeno imidazole carboxamide (DTIC) (NSC‐45388) in children with metastatic solid tumorsMedical and Pediatric Oncology, 1976
- The management of abdominal neuroblastomaCancer, 1975
- Histologic patterns of neuroblastoma related to prognosis and clinical stagingCancer, 1974
- Neuroblastoma, Its Natural History and Prognosis: A Study of 487 CasesBMJ, 1974
- The impact of chemotherapy on advanced neuroblastoma. Survival of patients diagnosed in 1956, 1962, and 1966–68 in Children's Cancer Study Group AThe Journal of Pediatrics, 1974
- Demonstration of cell-bound and humoral immunity against neuroblastoma cells.Proceedings of the National Academy of Sciences, 1968
- NeuroblastomaAnnals of Surgery, 1968